Back to results
US 2016/0106780 A1Published application
Methods and Compositions for Optimized Expansion and Implantation of Mesenchymal Stem Cells
AssigneeRegenerative Sciences, LLC
InventorsChristopher J. Centeno, Cristin Keohan
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided for the optimized expansion and implantation of mesenchymal stem cells into a patient in need thereof. Autologous mesenchymal stem cells (MSCs) to a patient in need of MSCs are harvested, expanded within novel growth parameters under the influence of autologous growth factors located on the patient's platelets.
Claims11
1-32. (canceled)
A method of expanding mesenchymal stem cells (MSC) in vitro for use in an implant to regenerate cartilage, the method comprising:
- (a) obtaining mesenchymal stem cells (MSCs) from an older patient in the 5th to 7th decade of life who is diagnosed with osteoarthritis, avascular necrosis, or severe degenerative joint disease;
- (b) expanding the MSCs with a growth medium comprising the patient's platelet lysate in an initial amount of between 5% and 20% of the growth medium for at least one passage to obtain at least 10 million to 100 million cells;
- (c) determining whether the MSCs of step (b) are outside the scope of one or more of the following parameters:
- (i) a doubling time of about 1 to about 3 days;
- (ii) cellular confluence greater than about 27 calculated according to the equation
- Surface area x(%Confluence)/Cell Number;
- (iii) random distribution of MSCs as a monolayer culture;
- or
- (iv) greater than 30% of MSCs without a spindle shape;
- and
- (d) adjusting the culture conditions in at least one following passage wherein the MSC are outside of the scope of at least one parameter in step (c) by at least one of:
- adjusting the amount of platelet lysate in the growth medium to between 15-20% platelet lysate, or by reseeding the MSC at a higher density than used in the original seeding;
- wherein the expanded MSCs are capable of regenerating new cartilage when implanted into the patient at a site in need thereof no later than the tenth ex-vivo passage.
10 more elements
Dependencies are inferred from the claim text.